Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · IEX Real-Time Price · USD

4.260

-0.130 (-2.96%)

At close: Jul 19, 2024, 4:00 PM

4.210

-0.050 (-1.17%)

Pre-market: Jul 22, 2024, 8:14 AM EDT

Monte Rosa Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-135.28	-135.35	-108.5	-73.96	-35.88	-7.74
Depreciation & Amortization	6.97	6.22	8.56	2.13	0.54	0.07
Share-Based Compensation	17.57	16.67	11.66	5.2	0.35	0
Other Operating Activities	52.19	68.66	-4.19	7.26	11.94	1.5
Operating Cash Flow	-58.56	-43.8	-92.47	-59.36	-23.05	-6.17
Capital Expenditures	-11.18	-18.98	-12.8	-9.65	-3.39	-1.39
Change in Investments	89.51	107.78	-206.42	0	0	0
Investing Cash Flow	78.33	88.8	-219.22	-9.65	-3.39	-1.39
Share Issuance / Repurchase	2.84	2.61	20.47	237.9	0	0
Debt Issued / Paid	0	0	0	0	0	0.75
Other Financing Activities	24.88	24.88	-	139.66	60.06	14.25
Financing Cash Flow	27.72	27.49	20.47	377.56	60.06	15
Net Cash Flow	47.49	72.49	-291.22	308.55	33.62	7.44
Free Cash Flow	-69.74	-62.78	-105.27	-69.02	-26.44	-7.56
Free Cash Flow Margin	-6554.79%	-	-	-	-	-
Free Cash Flow Per Share	-1.16	-1.22	-2.23	-2.76	-17.43	-1.51

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).